Heyjun Park

Heyjun Park

Auto-generated profile, based on publicly available information

Heyjun Park

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
HPHeyjun Park
Heyjun Park
MWMadeleine R Wood
Madeleine R Wood
OMOlga V Malysheva
Olga V Malysheva
SJSara Jones
Sara Jones
Saurabh MehtaSaurabh Mehta
Saurabh Mehta
MCMarie A. Caudill
Marie A. Caudill

1 August 2016 in The Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
HPHeyjun Park
Heyjun Park
PBPatsy M Brannon
Patsy M Brannon
AWAllyson A West
Allyson A West
JYJian Yan
Jian Yan
XJXinyin Jiang
Xinyin Jiang
MCMarie A. Caudill
Marie A. Caudill
Background: The impact of the reproductive state on vitamin D metabolism and requirements is uncertain in part because of a lack of studies with contr

1 February 2017 in Bone
Verified
Journal Article
Closed access
HPHeyjun Park
Heyjun Park
PBPatsy M. Brannon
Patsy M. Brannon
AWAllyson A. West
Allyson A. West
JYJian Yan
Jian Yan
XJXinyin Jiang
Xinyin Jiang
MCMarie A. Caudill
Marie A. Caudill

6 September 2024 in medRxiv
Verified
Preprint
Open access
PDF file
HPHeyjun Park
Heyjun Park
Ahmed MetwallyAhmed Metwally
Ahmed Metwally
ADAlireza Delfarah
Alireza Delfarah
YWYue Wu
Yue Wu
DPDalia Perelman
Dalia Perelman
MSMichael P Snyder
Michael P Snyder
This study examined the relationship between lifestyles (diet, sleep, and physical activity) and glucose responses at a personal level. 36 healthy adults in the Bay Area were monitored for their lifestyles and glucose levels using wearables and continuous glucose monitoring ( NCT03919877 ). Gold-standard metabolic tests were conducted to phenotype metabolic characteristics. Through the lifestyle data (2,307 meals, 1,809 nights, and 2,447 days) and 231,206 CGM readings from metabolically-phenotyped individuals with normoglycemia or prediabetes, we found: 1) eating timing was associated with hyperglycemia, muscle insulin resistance (IR), and incretin dysfunction, whereas nutrient intakes were not; 2) timing of increased activity in muscle IS and IR participants was associated with differential benefits of glucose control; 3) Integrated ML models using lifestyle factors predicted distinct metabolic characteristics (muscle, adipose IR or incretin dysfunction). Our data indicate the differential impact of lifestyles on glucose regulation among individuals with different metabolic phenotypes, highlighting the value of personalized lifestyle modifications.

14 April 2026 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
Ahmed MetwallyAhmed Metwally
Ahmed Metwally
HPHeyjun Park
Heyjun Park
YWyue wu
yue wu
TMTracey McLaughlin
Tracey McLaughlin
MSMichael P Snyder
Michael P Snyder
The classification of diabetes and prediabetes by static glucose thresholds obscures the pathophysiological dysglycemia heterogeneity, primarily driven by insulin resistance (IR), β-cell dysfunction, and incretin deficiency. This review demonstrates that continuous glucose monitoring (CGM) and wearable technologies enable a paradigm shift toward non-invasive, dynamic metabolic phenotyping. We show evidence that machine learning models can leverage high-resolution glucose data from at-home, CGM-enabled oral glucose tolerance tests to accurately predict gold-standard measures of muscle IR and β-cell function. This personalized characterization extends to real-world nutrition, where an individual’s unique postprandial glycemic response (PPGR) to standardized meals, such as the relative glucose spike to potatoes versus grapes, could serve as a biomarker for their metabolic subtype. Moreover, integrating wearable data reveals that habitual diet, sleep, and physical activity patterns, particularly their timing, are uniquely associated with specific metabolic dysfunctions, informing precision lifestyle interventions. The efficacy of dietary mitigators in attenuating PPGR is also shown to be phenotype-dependent. Collectively, this evidence demonstrates that CGM can deconstruct the complexity of early dysglycemia into distinct, actionable subphenotypes. This approach moves beyond simple glycemic control, paving the way for targeted nutritional, behavioral, and pharmacological strategies tailored to an individual’s core metabolic defects, thereby paving the way for a new era of precision diabetes prevention.

7 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
PMPetra Mamic
Petra Mamic
HSHanduo Shi
Handuo Shi
WZWenyu Zhou
Wenyu Zhou
NBNasim Bararpour
Nasim Bararpour
KCKevin Contrepois
Kevin Contrepois
MSMichael P Snyder
Michael P Snyder
Chronic systolic heart failure (HF) is a prevalent and morbid disease with marked variability in its progression and response to therapies. The gut microbiome may play a role in pathophysiology and progression of chronic HF, but clinical studies investigating relationships between the two are lacking. We analyzed the gut microbiome in a cohort of adults with chronic systolic HF caused by non-ischemic cardiomyopathy ( n =59) using multi-omics profiling and, in some cases, longitudinal sampling. We identified microbiome differences compared to healthy subjects ( n =50) and associated these differences with host metabolites, inflammatory markers and physiology. We found depletion of the anti-inflammatory probiotic Bifidobacterium and the associated short chain fatty acid producing and formaldehyde detoxifying pathways in the chronic HF cohort. We also discovered HF-specific microbiome-host immunome interactions. In addition to identifying several taxa and microbial pathways broadly associated with HF disease severity, we found significant links between Bifidobacterium and clinical HF improvement over time. Gut microbiome-host multi-omic data integration revealed a close association between Bifidobacterium and circulating metabolites previously implicated in cardiovascular physiology (e.g., malonic acid), thus pointing to potential mechanisms through which Bifidobacterium may affect chronic HF physiology. Our results suggest that Bifidobacterium may serve as a biomarker for chronic HF trajectory as well as suggest potential novel therapeutic interventions strategies.